NasdaqGS - Delayed Quote USD
Scholar Rock Holding Corporation (SRRK)
30.55
-0.28
(-0.91%)
At close: May 16 at 4:00:01 PM EDT
30.17
-0.38
(-1.24%)
After hours: May 16 at 7:02:36 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | -0.64 | -0.66 | -2.46 | -1.38 |
| Low Estimate | -0.69 | -0.72 | -2.73 | -1.96 |
| High Estimate | -0.57 | -0.56 | -2.23 | -0.38 |
| Year Ago EPS | -0.6 | -0.66 | -2.47 | -2.46 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | -- | 250k | 7.09M | 158.87M |
| Low Estimate | -- | -- | 1.62M | 76M |
| High Estimate | -- | 1M | 20M | 253.62M |
| Year Ago Sales | -- | -- | -- | 7.09M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 2,141.47% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.59 | -0.59 | -0.63 | -0.71 |
| EPS Actual | -0.6 | -0.66 | -0.61 | -0.67 |
| Difference | -0.01 | -0.07 | 0.02 | 0.04 |
| Surprise % | -1.82% | -12.19% | 2.99% | 5.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.64 | -0.66 | -2.46 | -1.38 |
| 7 Days Ago | -0.68 | -0.71 | -2.62 | -0.81 |
| 30 Days Ago | -0.68 | -0.71 | -2.62 | -0.81 |
| 60 Days Ago | -0.68 | -0.71 | -2.62 | -0.81 |
| 90 Days Ago | -0.68 | -0.71 | -2.23 | -0.2 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 3 | 3 | 3 | 2 |
| Down Last 30 Days | 3 | 3 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SRRK | -6.67% | 0.00% | 0.45% | 43.73% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/26/2024 |
| Maintains | Wedbush: Outperform to Outperform | 11/25/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/25/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/15/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/14/2024 |
Related Tickers
MRUS Merus N.V.
41.56
+3.69%
ACLX Arcellx, Inc.
58.78
+0.56%
BHVN Biohaven Ltd.
16.02
+1.26%
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
CYTK Cytokinetics, Incorporated
31.00
+3.89%
CRNX Crinetics Pharmaceuticals, Inc.
31.24
+0.10%
STOK Stoke Therapeutics, Inc.
9.76
+1.35%
REPL Replimune Group, Inc.
7.85
+8.58%
ETNB 89bio, Inc.
7.78
+1.77%
MLTX MoonLake Immunotherapeutics
37.62
-0.11%